Crispr Therapeutics shares owned by Waddell & Reed Financial
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Waddell & Reed Financial
from 13F filings
Historical chart of Waddell & Reed Financial investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Waddell & Reed Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Waddell & Reed Financial
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2021-03-31 | $131M | 1.1M | 121.85 |
| 2020-12-31 | $186M | 1.2M | 153.11 |
| 2020-09-30 | $110M | 1.3M | 83.64 |
| 2020-06-30 | $76M | 1.0M | 73.49 |
| 2020-03-31 | $44M | 1.0M | 42.41 |
| 2019-12-31 | $63M | 1.0M | 60.91 |
| 2019-09-30 | $43M | 1.0M | 40.99 |
| 2019-06-30 | $47M | 1.0M | 47.10 |
| 2019-03-31 | $36M | 1.0M | 35.72 |
| 2018-12-31 | $29M | 1.0M | 28.57 |
| 2018-09-30 | $44M | 1.0M | 44.35 |